Drug-resistant Plasmodium falciparum infection in immigrants and non-immune travellers

Clin Microbiol Infect. 2002 Nov;8(11):734-8. doi: 10.1046/j.1469-0691.2002.00451.x.

Abstract

Objective: To detect the incidence of drug-resistant Plasmodium falciparum malaria infection in immigrants and travellers in non-endemic Kuwait.

Methods: Over a period of 3 years, July 1995 to September 1998, 1352 malaria patients were enrolled in the study. Of these, 1293 were immigrants from countries where malaria is endemic and 59 were non-immune travellers with a recent history of travel to these countries. The in vitro drug sensitivity was determined in 892 patients.

Results: In all, 892 of 1352 (66.0%) P. falciparum isolates were successfully cultured in vitro for drug sensitivity and 419 (47.0%) isolates showed in vitro resistance to chloroquine or mefloquine. Fifty-six (13.4%) isolates were resistant to both drugs. Chloroquine resistance was observed in > 70% of the isolates from Africa and India followed by Pakistan (39.9%) and Bangladesh (35.9%). The resistance to mefloquine ranged from 26.2% in isolates from Sri Lanka to 47.5% in isolates from African countries.

Conclusion: The study highlights the important trend in drug resistance in P. falciparum malaria in immigrants from south-east Asian and African countries.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Africa
  • Animals
  • Antimalarials / pharmacology*
  • Antimalarials / therapeutic use
  • Asia, Southeastern
  • Chloroquine / pharmacology
  • Chloroquine / therapeutic use
  • Drug Resistance*
  • Emigration and Immigration*
  • Female
  • Humans
  • Inhibitory Concentration 50
  • Kuwait / epidemiology
  • Malaria, Falciparum / drug therapy
  • Malaria, Falciparum / epidemiology*
  • Malaria, Falciparum / parasitology*
  • Malaria, Falciparum / prevention & control
  • Male
  • Mefloquine / pharmacology
  • Mefloquine / therapeutic use
  • Plasmodium falciparum / drug effects*
  • Travel*

Substances

  • Antimalarials
  • Chloroquine
  • Mefloquine